Mahesh Anantha Narayanan et al. JACEP 2017;3:

Slides:

Advertisements

Similar presentations

The MADIT II Trial Multicenter Autonomic Defibrillator Implantation Trial II Presented at the American College of Cardiology 51st Annual Scientific Session.

Advertisements

Cardiac Resynchronization Heart Failure Study Cardiac Resynchronization Heart Failure Study Presented at American College of Cardiology Scientific Sessions.

Implantable Cardioverter Defibrillators to Prevent Sudden Cardiac Death: Background Frederick A. Masoudi, MD, MSPH Associate Professor of Medicine (Cardiology)

PACT Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director of the Joseph J Jacobs Center for Thrombosis and.

Implantable Cardioverter Defibrillator Rebecca Boduch Biomedical Engineering University of Rhode Island.

ICD FOR PRIMARY PREVENTION EVIDENCE REVIEW

Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.

EP Show – Aug 2003 ICDs – Primary prevention The EP Show: Which ICD for which patient? Part 2: Primary prevention Eric Prystowsky MD Director, Clinical.

IRIS Post-hoc Analysis Background IRIS compared the safety and efficacy of early ICD implantation with medical treatment alone in 898 patients at high.

An ICD for every CRT patient ?

Date of download: 6/1/2016 From: Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure Ann Intern Med. 2004;141(5):

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Ventricular Tachyarrhythmias With Statins.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Effectiveness of CRT and ICD Therapy in.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effect of Intermittent Atrial Tachyarrhythmia.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction of the Risk of Recurring Heart Failure.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Influence of Left Ventricular Ejection Fraction.

Ventricular Arrhythmias:A General Cardiologist’s Assessment of Therapies in 2004 C.Richard Conti M.D. MACC.

Defibrillator in Acute Myocardial Infarction Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Drs. Stewart Connelly.

Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in CKD: A Meta-analysis of Patient-Level Data From 3 Randomized.

Copyright © 2011 American Medical Association. All rights reserved.

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,

Journal of Cardiac Failure

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;

Defibrillator in Acute Myocardial Infarction Trial

American College of Cardiology Presented by Dr. Stuart J. Connolly

José L. Morales et al. JACEP 2017;j.jacep

Preventing SCD With a WCD: Reviewing the Results of the VEST Trial

BENEFIT Trial design: Patients with positive serologic tests for T. Cruzi and cardiomyopathy were randomized to benznidazole 300 mg daily for days.

DANISH Trial design: Patients with nonischemic cardiomyopathy were randomized to ICD implantation (n = 556) versus usual care (n = 560). Results (p = 0.28)

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection Derek V. Exner, MD, MPH, David.

Clyde W. Yancy et al. JACC 2017;70:

Erratum Heart Rhythm Volume 8, Issue 4, (April 2011)

Noriko Kikuchi et al. JACEP 2016;2:

Ragavendra R. Baliga, MD, MBA Heart Failure Clinics

José L. Morales et al. JACEP 2017;j.jacep

Francisco Leyva et al. JACC 2017;70:

Gaurav A. Upadhyay, MD, Jonathan S. Steinberg, MD Heart Rhythm

David D. Berg et al. JACC 2018;71:

Misconceptions and Facts About Hypertrophic Cardiomyopathy

Angelo Auricchio, and Frits W. Prinzen JACEP 2017;3:

Tom F. Brouwer et al. JACEP 2016;2:

Belinda Gray et al. JCHF 2013;1:

David F. Katz et al. JACEP 2016;j.jacep

Zachary R. McCaw, AM, Ariela R

Mintu P. Turakhia et al. JACEP 2016;2:

Volume 15, Issue 10, Pages e253-e274 (October 2018)

Imran Niazi et al. JACEP 2017;j.jacep

Mohit K. Turagam et al. JACEP 2017;3:

Prabhat Kumar et al. JACEP 2016;j.jacep

Ethnic and racial disparities in cardiac resynchronization therapy

Angelo Auricchio, and Frits W. Prinzen JACEP 2017;j.jacep

Prabhat Kumar et al. JACEP 2016;j.jacep

Kenshi Hayashi et al. JACEP 2016;2:

Volume 7, Issue 7, Pages (July 2010)

David F. Katz et al. JACEP 2017;3:20-28

Volume 12, Issue 10, Pages (October 2015)

Stuart A. Ostby et al. JACEP 2016;2:

Ayman A. Hussein et al. JACEP 2017;3:1-9

Emilce Trucco et al. JACEP 2018;j.jacep

Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep

Matthew M. Zipse et al. JACEP 2015;1:94-102

Volume 8, Issue 3, Pages (March 2011)

Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep

Stavros V. Konstantinides et al. JACC 2017;69:

Saadia Sherazi et al. JACEP 2015;1:74-80

Results of comparisons of treatments in the network.

Jeffrey Senfield et al. JACEP 2017;3:

Rethinking Risk Stratification for Nonischemic HF:

Daniele Muser et al. JACEP 2017;j.jacep

(A). (A). Kaplan-Meier plot of event-free survival in 27 LMNA mutation carriers and 78 DCM control patients. Death, heart transplantation, resuscitation.

Presentation transcript:

Mahesh Anantha Narayanan et al. JACEP 2017;3:962-970 Design of the Analysis and the Comparison Groups *No-ICD group in SCD-HeFT consists of both amiodarone and placebo arms. AMIOVIRT = Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic non-sustained ventricular tachycardia; CAT = Cardiomyopathy Trial; COMPANION = Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure; CRT = cardiac resynchronization therapy; CRT-D = cardiac resynchronization therapy–defibrillator; CRT-P = cardiac resynchronization therapy–pacemaker; DANISH = Danish Study to Assess the Efficacy of ICDs in Patients with Non-Ischemic Systolic Heart Failure on Mortality; DEFINITE = Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation; ICD = implantable cardioverter-defibrillator; SCD-HeFT = Sudden Cardiac Death in Heart Failure Trial. Mahesh Anantha Narayanan et al. JACEP 2017;3:962-970 2017 American College of Cardiology Foundation